Cannabinoids in Pediatric Care: Clinical Evidence Review
This review focuses on cannabinoid safety pediatric use, summarizing evidence from 276 studies including interventional and observational research. The clinical evidence supports cautious use of cannabinoids in pediatric medicine for select conditions.…
Mom’s Homemade Medical Cannabis Recipe Now Sold at Georgia Dispensaries
Patient-derived cannabis formulations are now being sold at Georgia dispensaries, raising important safety and quality concerns. This shift impacts pediatric autism treatment options and clinical guidance. Clinicians should stay informed about these…
Understanding Oregon Cannabis Edible Safety and Pediatric Risks
Oregon cannabis edible safety is a growing concern due to failed THC potency limits. Pediatric cannabis exposure risks remain high with unregulated edibles. Clinicians emphasize safe storage and education to prevent accidental ingestion.
Endocannabinoid System Research: Cannabinoids in Pediatrics
Cannabinoids pediatric research is expanding with numerous studies examining safety and efficacy in children. This living systematic review highlights 276 studies across various pediatric conditions. Clinicians should consider this evolving evidence base…
Kids as Young as 11 Being Treated for Cannabis Use Disorder, Children’s National Hospital Says
Cannabis use disorder in children is an emerging concern requiring early screening and intervention. Children as young as 11 are being treated for this disorder. Understanding youth cannabis accessibility helps inform prevention strategies.
Medical Cannabis Evidence-Based Care: CBD Autism RCT
This CBD autism clinical trial investigated oral CBD oil effects on social behavior, anxiety, and parental stress in autistic children. The randomized controlled crossover design provided rigorous evidence. Results suggest potential benefits of CBD in…
Cannabinoids in Pediatric Medicine: Evidence-Based Review
Cannabinoid clinical trials pediatric research provides evolving evidence on safety and efficacy in children. This review highlights cautious clinical consideration where conventional treatments fall short. Ongoing studies continue to inform best…
Cannabis Adolescent Psychiatric Risk Data Study Insights
This cannabis adolescent psychiatric risk data study highlights new concerns about marijuana use in teens and its association with psychiatric conditions. The developing adolescent brain is particularly vulnerable to cannabis effects, increasing risks…
Cannabis Tax Revenue Decline and Market Trends in 2026
The cannabis tax revenue decline in Michigan highlights shifting market dynamics affecting recreational cannabis sales. This trend signals changes in consumer behavior and regulatory impacts. Understanding cannabis tax revenue decline is crucial for…
Cognitive Safety in Older Adults: Latest Cannabis Insights
This digest highlights recent research on cognitive safety in older adults using cannabis, addressing dementia risk and clinical implications. It also covers advances in end-of-life cannabis access and ongoing regulatory friction. These insights provide…
